{
  "content": "Abstract\nOBJECTIVES\nThe purpose of this study was to investigate the efficacy and safety of amiodarone and propafenone in the conversion of chronic atrial fibrillation in a prospective, randomized, placebo-controlled study.\nBACKGROUND\nThe effectiveness of amiodarone and propafenone in the treatment of patients with chronic atrial fibrillation has not been adequately studied.\nMETHODS",
  "source": "https://www.jacc.org/doi/10.1016/S0735-1097%2898%2900678-0",
  "chunk_id": "e2b6bbc4-65e7-44bd-b60f-1ec9048e66cc",
  "similarity_score": 0.3940993547439575,
  "query": "amiodarone versus beta-blockers atrial fibrillation randomized controlled trial efficacy comparison",
  "rank": 19,
  "title": "Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study",
  "authors": "George E Kochiadakis, Nikos E Igoumenidis, Fragiskos I Parthenakis, Gregory I Chlouverakis, Panos E Vardas",
  "year": "1999",
  "journal": "Journal of the American College of Cardiology",
  "reference": "Kochiadakis, G. E., Igoumenidis, N. E., Parthenakis, F. I., Chlouverakis, G. I., & Vardas, P. E. (1999). Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. Journal of the American College of Cardiology, 33(4), 328-334.",
  "doi": "Not available",
  "chunk_index": 4,
  "total_chunks": 73,
  "retrieved_at": "2025-07-24T22:33:10.541034"
}